Drugs / COVID19-0001-USR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04595136 | Nov 2020 → Jul 2021 | COVID-19 | United Medical Specialties | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID19-0001-USR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04595136 ↗ |
| Route | Inhaled | “administered via nebulization/inhalation” NCT04595136 ↗ |